regulatory
confidence high
sentiment negative
materiality 0.80
Vivakor receives Nasdaq bid price deficiency notice; issues $6.625M convertible note
Vivakor, Inc.
- Nasdaq deficiency letter for bid price <$1.00 for 30 days; 180-day cure period ends Sept 15, 2025.
- Issued $6.625M junior secured convertible note to J.J. Astor & Co.; net $5M received after fees.
- Note payable in 42 weekly installments of $157,739; may be paid in shares at 20% discount to market.
- Issued 250,000 commitment shares as additional consideration; registration rights agreement filed.
- Existing senior debt ~$48.5M; convertible note is junior secured with mandatory prepayment from equity receipts.